PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.58%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-40.04%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-37.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
46.26%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
49.37%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
49.94%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-16.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-16.23%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
52.63%
Dividend growth of 52.63% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
1.12%
OCF growth under 50% of AR's 7.56%. Michael Burry might suspect questionable revenue recognition or rising costs.
25.48%
FCF growth above 1.5x AR's 15.38%. David Dodd would verify if the firm’s strategic investments yield superior returns.
139.84%
10Y revenue/share CAGR at 50-75% of AR's 226.56%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
139.84%
5Y revenue/share CAGR above 1.5x AR's 76.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
152.42%
Positive 3Y CAGR while AR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
467.41%
10Y OCF/share CAGR above 1.5x AR's 83.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
467.41%
5Y OCF/share CAGR above 1.5x AR's 266.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
195.65%
Positive 3Y OCF/share CAGR while AR is negative. John Neff might see a big short-term edge in operational efficiency.
697.91%
Net income/share CAGR above 1.5x AR's 196.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
697.91%
5Y net income/share CAGR above 1.5x AR's 129.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
332.86%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
135.21%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
135.21%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
149.39%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
146.65%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
146.65%
Dividend/share CAGR of 146.65% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
173.31%
3Y dividend/share CAGR of 173.31% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.17%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
21.05%
Inventory growth of 21.05% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.76%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
29.82%
BV/share growth above 1.5x AR's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-89.96%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.